Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease

Vaccine

Volumn 26, Issue 4, 2008, Pages 502-508

  Pannaraj, Pia S ^a   Kelly, Joanna K ^a   Rench, Marcia A ^a   Madoff, Lawrence C ^b   Edwards, Morven S ^a   Baker, Carol J ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Alpha C protein; Conjugate vaccine; Group B Streptococcus

Indexed keywords

ALPHA C PROTEIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; PROTEIN C; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNITY; NEWBORN; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, SURFACE; BACTEREMIA; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; FEMALE; FETAL BLOOD; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT, NEWBORN; PHAGOCYTOSIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 37849027478     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.034     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. Early-onset and late-onset neonatal group B streptococcal disease-United States, 1996-2004. MMWR Morb Mortal Wkly Rep 2005;54:1205-8.
2. Schrag S.J., Zywicki S., Farley M.M., Reingold A.L., Harrison L.H., Lefkowitz L.B., et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342 (2000) 15-20
3. Sinha A., Lieu T.A., Paoletti L.C., Weinstein M.C., and Platt R. The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. Vaccine 23 (2005) 3187-3195
4. Paoletti L.C., and Madoff L.C. Vaccines to prevent neonatal GBS infection. Semin Neonatol 7 (2005) 315-323
5. Kasper D.L., Paoletti L.C., Wessels M.R., Guttormsen H.K., Carey V.J., Jennings H.J., et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest 98 (1996) 2308-2314
6. Johnson D.R., and Ferrieri P. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol 19 (1984) 506-510
7. Manning S.D., Ki M., Marrs C.F., Kugeler K.J., Borchardt S.M., Baker C.J., et al. The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates. BMC Infect Dis 6 (2006) 116-123
8. Michel J.L., Madoff L.C., Olson K., Kling D.E., Kasper D.L., and Ausubel F.M. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc Natl Acad Sci 89 (1992) 10060-10064
9. Baron M.J., Bolduc G.R., Goldberg M.B., Auperin T.C., and Madoff L.C. Alpha C protein of group B Streptococcus binds host cell surface glycosaminoglycan and enters cells by an actin-dependent mechanism. J Biol Chem 279 (2004) 24714-24723
10. Baron M.J., Filman D.J., Prophete G.A., Hogle J.M., and Madoff L.C. Identification of a glycosaminoglycan binding region of the alpha C protein that mediates entry of group B streptococci into host cells. J Biol Chem 282 (2007) 10526-10536
11. Gravekamp C., Kasper D.L., Paoletti L.C., and Madoff L.C. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines. Infect Immun 67 (1999) 2491-2496
12. Bevanger L. The Ibc proteins of group B streptococci: isolation of the α and β antigens by immunosorbent chromatography and test for human serum antibodies against the two antigens. Acta Path Microbiol Immunol Scand 93 (1985) 113-119
13. Larsson C., Lindroth M., Nordin P., Stalhammar-Carlemalm M., Lindahl G., and Krantz I. Association between low concentrations of antibodies to protein α and Rib and invasive neonatal group B streptococcal infection. Arch Dis Child Fetal Neonatal Ed 91 (2006) F403-F408
14. Campbell J.R., Hillier S.L., Krohn M.A., Ferrieri P., Zaleznik D.F., and Baker C.J. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol 96 (2000) 498-503
15. Lancefield R.C. Serologic differentiation of specific types of bovine hemolytic streptococci. J Exp Med 59 (1934) 441-458
16. Benson J.A., Flores A.E., Baker C.J., Hillier S.L., and Ferrieri P. Improved methods for typing nontypeable isolates of group B Streptococcus. Int J Med Microbiol 292 (2002) 37-42
17. Pannaraj P.S., Kelly J.K., Madoff L.C., Rench M.A., Lachenauer C.S., Edwards M.S., et al. Group B Streptococcus bacteremia elicits beta C protein-specific IgM and IgG in humans. J Infect Dis 195 (2007) 353-356
18. Gravekamp C., Horensky D.S., Michel J.L., and Madoff L.C. Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes. Infect Immun 64 (1996) 3576-3583
19. Ramaswamy S.V., Ferrieri P., Flores A.E., and Paoletti L.C. Molecular characterization of nontypeable group B Streptococcus. J Clin Microbiol 44 (2006) 2398-2403
20. Edwards M.S., Baker C.J., and Kasper D.L. Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus. J Infect Dis 140 (1979) 1004-1008
21. Lancefield R.C., McCarty M., and Everly W. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med 142 (1975) 165-179
22. Bevanger L., and Naess A.I. Mouse-protective antibodies against the Ibc proteins of group B streptococci. Acta Pathol Microbiol Immunol Scand [B] 93 (1985) 121-124
23. Madoff L.C., Michel J.L., and Kasper D.L. A monoclonal antibody identified a protective C-protein alpha-antigen epitope in group B streptococci. Infect Immun 59 (1991) 204-210
24. Michel J.L., Madoff L.C., Kling D.E., Kasper D.L., and Ausubel F.M. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect Immun 59 (1991) 2023-2028
25. Larsson C., Stalhammar-Carlemalm M., and Lindahl G. Experimental vaccination against Group B Streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins rib and α. Infect Immun 64 (1996) 3518-3523
26. Baker C.J., and Kasper D.L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 294 (1976) 753-756
27. Gotoff S.P., Papierniak C.K., Klegerman M.E., and Boyer K.M. Quantitation of IgG antibody to the type-specific polysaccharide of group B Streptococcus type 1b in pregnant women and infected infants. J Pediatr 105 (1984) 628-630
28. Davies H.D., Adair C., McGeer A., Ma D., Robertson S., Mucenski M., et al. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. J Infect Dis 184 (2001) 285-291
29. Madoff L.C., Michel J.L., Gong E.W., Kling D.E., and Kasper D.L. Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. Proc Natl Acad Sci 93 (1996) 4131-4136
30. Madoff L.C., Hori S., Michel J.L., Baker C.J., and Kasper D.L. Phenotypic diversity in the alpha C protein of Group B streptococci. Infect Immun 59 (1991) 2638-2644
31. Harrison L.H., Elliott J.A., Dwyer D.M., Libonati J.P., Ferrieri P., Billmann L., et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J Infect Dis 177 (1998) 998-1002